{
    "clinical_study": {
        "@rank": "95813", 
        "acronym": "VIVID", 
        "arm_group": [
            {
                "arm_group_label": "Learning", 
                "arm_group_type": "Experimental", 
                "description": "Visual perceptual learning (VPL) group"
            }, 
            {
                "arm_group_label": "Control", 
                "arm_group_type": "No Intervention", 
                "description": "Control group"
            }
        ], 
        "brief_summary": {
            "textblock": "This study will test the hypothesis whether visual field defect caused by chronic stroke\n      could be improved by visual perceptual learning. The secondary hypothesis is that\n      improvement of visual field defect would be accompanied by connectivity changes in visual\n      networks. In addition, investigators will evaluate whether improvement of visual field\n      defect could achieve improvement of subjective visual function."
        }, 
        "brief_title": "Visual Perceptual Learning for the Treatment of Visual Field Defect", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Stroke", 
            "Visual Field Defect"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Scotoma", 
                "Stroke"
            ]
        }, 
        "detailed_description": {
            "textblock": "Study design: A PROBE (Prospective, Randomized, Open-label, Blinded-endpoint) design\n\n      Methods:\n\n        1. Visual perceptual learning (VPL) group\n\n             1. Visual perceptual learning (24 times for 2 months, 3 times per week) in visual\n                field defect areas\n\n             2. At baseline and post-VPL evaluations (2 months after): Structural & Functional\n                MRIs, Visual field tests, Visual evoked potential, Visual cognitive tests,\n                Subjective visual function questionnaires\n\n        2. Control group\n\n             1. At baseline and 2-months later: No VPL, Structural & Functional MRIs, Visual field\n                tests, Visual evoked potential, Visual cognitive tests, Subjective visual function\n                questionnaires\n\n             2. Visual perceptual learning after 2-month follow-up evaluation (24 times for 2\n                months, 3 times per week)\n\n           (The patients who were stratified by age (over 65 years old or not) and degree of\n           visual field defect (quadrantanopia or complete hemianopia) will be randomly assigned\n           into the learning and control group.)\n\n        3. Investigations\n\n             1. Improvement of visual field test scores between VPL group and control group\n\n             2. Analysis of brain network changes in MRI data\n\n             3. Correlation analysis of improvement of visual field defect and MRI data\n\n             4. Correlation analysis of improvement of visual field defect and visual evoked\n                potential (VEP) data\n\n             5. Correlation analysis of improvement of visual field defect and neuropsychological\n                data"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. The patient has chronic stroke more than 6 months after onset.\n\n          2. The patient has visual field defect (Quadrantanopia or Hemianopia).\n\n          3. The patient has corrected eyesight 0.7 or above.\n\n        Exclusion Criteria:\n\n          1. The patient has contraindication to MRI scan.\n\n          2. The patient has cognitive impairment (Mini-Mental Status Exam score <24).\n\n          3. The patient has ophthalmologic diseases (e.g., glaucoma, cataract)."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "20 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 7, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01959256", 
            "org_study_id": "VIVID"
        }, 
        "intervention": {
            "arm_group_label": "Learning", 
            "description": "24 times of training for visual perceptual learning", 
            "intervention_name": "Visual perceptual learning", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Stroke", 
            "Visual Field Defect", 
            "Visual perceptual learning", 
            "Brain connectivity"
        ], 
        "lastchanged_date": "April 10, 2014", 
        "location": {
            "contact": {
                "email": "dwkang@amg.seoul.kr", 
                "last_name": "Dong-Wha Kang, MD, PhD", 
                "phone": "82-2-3010-3440"
            }, 
            "facility": {
                "address": {
                    "city": "Seoul", 
                    "country": "Korea, Republic of", 
                    "zip": "138-736"
                }, 
                "name": "Asan Medical Center"
            }, 
            "investigator": {
                "last_name": "Dong-Wha Kang, MD, PhD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Korea, Republic of"
        }, 
        "number_of_arms": "2", 
        "official_title": "Visual Perceptual Learning for the Treatment of Visual Field Defect", 
        "overall_contact": {
            "email": "dwkang@amc.seoul.kr", 
            "last_name": "Dong-Wha Kang, MD, PhD", 
            "phone": "82-2-3010-3440"
        }, 
        "overall_official": {
            "affiliation": "Asan Medical Center", 
            "last_name": "Dong-Wha Kang, MD, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "South Korea: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Improvement of mean deviation scores in defected areas by Humphrey 750i Field test", 
            "measure": "Improvement of visual field scores in visual field defect areas", 
            "safety_issue": "No", 
            "time_frame": "At 2 months (plus or minus 7 days) after baseline evaluation"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01959256"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Asan Medical Center", 
            "investigator_full_name": "Dong-Wha Kang", 
            "investigator_title": "MD, PhD", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Performance (scores) of visual perceptual learning", 
                "measure": "Performance of visual perceptual learning", 
                "safety_issue": "No", 
                "time_frame": "At 2 months (plus or minus 7 days) after baseline evaulation"
            }, 
            {
                "description": "Functional connectivity changes in resting-state functional MRI\nStructural connectivity changes in diffusion tensor imaging", 
                "measure": "Connectivity changes in MRI", 
                "safety_issue": "No", 
                "time_frame": "Between baseline and 2 months (plus or minus 7 days) after"
            }, 
            {
                "description": "Improvement of mean deviation scores in whole visual field by Humphrey 750i Field test", 
                "measure": "Improvement of visual field score in whole visual field area", 
                "safety_issue": "No", 
                "time_frame": "At 2 months (plus or minus 7days) after baseline evaluation"
            }, 
            {
                "description": "Change in Korean version of National Eye institute Visual Functioning Questionnaire-25 (NEI-VFQ-25)\nChange of subjective visual field area", 
                "measure": "Change of subjective visual function", 
                "safety_issue": "No", 
                "time_frame": "At 2 months (plus or minus 7days) after baseline evaluation"
            }, 
            {
                "description": "Changes between baseline and 2 months after in half-field visual evoked potential (VEP) data", 
                "measure": "Changes of visual evoked potential", 
                "safety_issue": "No", 
                "time_frame": "Between baseline and 2 months (plus or minus 7 days) after"
            }
        ], 
        "source": "Asan Medical Center", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Asan Medical Center", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}